Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TARS · against 300 other Healthcare companies of similar size
Ranked #121 of 301 · scores higher than 60% of peers · safety percentile 61
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)30 peers with a safety percentile of 60–69, including TARS · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | TARS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 295 reported | 0.26× | 0.23× | 47% | 33% | |
| BetaLower is better · 292 reported | 0.54 | 0.55 | 52% | 33% | |
| Current ratioHigher is better · 288 reported | 3.20× | 2.81× | 56% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 1.8B USD | 99 | 42 | |
| 117 | 22.0B CNY (≈$3.1B) | 63 | 67 | |
| 118 | 13.3B CNY (≈$1.9B) | 62 | 65 | |
| 119 | 182.3B INR (≈$2.2B) | 62 | 66 | |
| 120 | 70.9B ZAR (≈$3.9B) | 61 | 48 | |
| 121 | 3.4B USD | 61 | 48 | |
| 122 | 5.76T KRW (≈$4.1B) | 61 | 59 | |
| 123 | 1.8B USD | 60 | 80 | |
| 124 | 5.3B USD | 60 | 50 | |
| 125 | 34.2B CNY (≈$4.8B) | 60 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score